Achieve Life Sciences, Inc.
(NASDAQ : ACHV)

( )
ACHV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.99%59.150.0%$907.20m
AMGNAmgen, Inc. -0.77%256.251.3%$749.53m
GILDGilead Sciences, Inc. 0.54%76.761.0%$694.38m
REGNRegeneron Pharmaceuticals, Inc. 0.77%627.252.5%$662.27m
BIIBBiogen, Inc. 1.77%269.801.6%$578.06m
NVAXNovavax, Inc. -2.70%79.44102.0%$554.12m
VRTXVertex Pharmaceuticals, Inc. 0.07%291.311.9%$511.41m
ILMNIllumina, Inc. 1.69%379.393.5%$304.71m
ALXNAlexion Pharmaceuticals, Inc. 1.13%113.572.0%$235.48m
BMRNBioMarin Pharmaceutical, Inc. 0.73%127.714.3%$217.46m
SGENSeattle Genetics, Inc. 0.84%170.456.1%$198.74m
SRNESorrento Therapeutics, Inc. 4.60%7.171.8%$192.02m
IMMUImmunomedics, Inc. 8.23%40.6311.0%$178.71m
SRPTSarepta Therapeutics, Inc. 0.46%163.4913.9%$171.15m
INCYIncyte Corp. 1.24%107.792.5%$164.33m

Company Profile

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.